Conclusions
Survivors of ARDS after 6 months had a poorer HRQL than the healthy population and showed mild radiographic and functional involvement. Early HRQL study in these patients enabled early detection of those who would present more long-term HRQL morbidity. 
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ARDS is characterized by severe dyspnea and hypoxemia, requiring mechanical ventilation (MV) and ICU hospitalization. Despite the advances achieved in ventilatory management and general support, ARDS remains associated with elevated morbidity and mortality. [1] , [2] The current objective of intensive medicine in critically ill patients is not only to assure their survival, but also to attain the ideal outcome of health care. This may be returning patients to their preexisting state or to the state expected for a person of the same age and medical condition. [3] Therefore, one of the priorities in this field should be to determine and improve the quality of life and functional status of patients who have survived ARDS. Generally, outcome measures are divided into measures of impairment (lung volumes and radiographic studies), functional status (exercise test), and health-related quality of life (HRQL). [4] Traditionally, the assessment of critical care has focused largely on mortality. More recently, some studies have focused on the long-term life quality of these patients; however, none has additionally analyzed the effect that pulmonary morphofunctional sequelae may have on their HRQL. Nevertheless, some authors have detected radiographic and functional changes regarding the origin of ARDS and others a relationship between the origins and subsequent HRQL. [5] We hypothesized that survivors of ARDS present alterations in HRQL compared with a healthy reference population and that longterm pulmonary radiographic and functional abnormalities may be related to alterations in the HRQL of survivors of ARDS. Thus, the aims of this study were (1) to evaluate HRQL in 6-month survivors of ARDS compared with a healthy reference population, (2) to determine the middle/long-term radiographic abnormalities and functional status of these patients, and (3) to analyze the relation between HRQL and factors associated with the acute phase of critical illness or observed pulmonary radiographic and functional sequelae.
Materials and Methods
A detailed description of methods can be found in e-Appendix 1. Briefly, a prospective, observational, longitudinal study was carried out for 6 years in three ICUs in Barcelona, Spain. The study was approved by the ethics committee, and informed consent for participation was obtained initially from a next of kin and later confirmed by each patient.
During the study period, daily screening was performed of all patients admitted to the participating ICUs; those who met the criteria for ARDS [6] were included. Patients were followed up during their ICU stay and after transferral to a hospital ward. During the follow-up period, patients underwent a clinical interrogation and physical examination, and were asked to fill out the Spanish version of the Nottingham Health Profile (NHP) as an HRQL test. Reference values for a healthy population in Barcelona were obtained from an Institut Municipal d'Investigacions Mèdiques study. [7] Pulmonary function testing (PFT) was performed using the MasterLab system (MasterLab; Jaegger, Germany). All tests were done according to European Respiratory Society and American Thoracic Society guidelines. [8] Static lung volumes were measured using the plethysmography method, and diffusing capacity of the lung for carbon monoxide (DLCO) was measured using the single breath-hold method. [9] A high-resolution chest CT (HRCT) scan study was performed in the Radiology Department of Vall d'Hebron Hospital. The protocol consisted of a 1.0 to 1.5-mm-width slice at 10-mm intervals from the lung apex to the base. Two consultant thoracic radiologists, who were unaware of the clinical information and lung function results, scored all scans independently. When the radiologists disagreed, an independent consultant radiologist made the final decision. Each HRCT scan was assessed for the presence, pattern, and distribution of interstitial lung disease and airways disease (AD). Three different abnormal patterns were assessed: (1) ground glass pattern, (2) reticular pattern (RP), and (3) AD.
The exercise test (6-min walk test) was performed according to American Thoracic Society guidelines. [10] The variable persistent pulmonary morbidity, defined as the number of patients who presented saturation of ≤ 88% at any time during the exercise testing, was analyzed. [11] For the statistical analysis, categorical values are described as frequency and percentages and continuous variables as the mean and SD or median and interquartile range. To compare independent categorical variables, the χ 2 or Fisher exact test was used. Continuous variables were compared with the Student t test (two groups) and analysis of variance (more than two groups) for dependent or independent data. In the case of noncompliance with the parametric assumptions, nonparametric tests were used: analysis of variance with prior transformation of ranges for independent data and either the Wilcoxon test (two groups) or the Friedman test (more than two groups) for dependent data. The relationship of the total score with the remaining variables was examined by multiple regression analysis. Statistical significance was set at a two-tailed P value of ≤ .05, and all analyses were performed with SPSS, version 18.0 (SPSS Inc; Chicago, Illinois) and SAS, version 9.1.3 (SAS Institute Inc, Cary, North Carolina).
Results
General Characteristics of the Population Studied
A total of 204 patients were diagnosed with ARDS during the study period. The patient enrollment process is summarized in Figure 1 . The study population consisted of 38 patients evaluated in the 6-month follow-up, representing 43.1% of those included. Only 15 patients were able to respond to the HRQL test at 1 month (39.4% of the total of patients assessed at 6 months). The main characteristics of the population included in the 6-month study, the survivors who could not be included, and patients who did not survive are shown in Table 1 . 
Health-Related Quality of Life
At 6 months, ARDS survivors presented a poorer quality of life than the reference population (Fig 2, Table 2 ), with significant differences in three of the six NHP dimensions analyzed: mobility, energy, and social isolation. In the second part of the NHP questionnaire, which analyzed limitations in daily life activities (Fig 3) , the seven activities included were affected in 20% to 40% of patients, with the exception of family life, which was altered in only 10% of cases. The activities that were most persistently altered were both domestic and professional tasks. 
Pulmonary Function Testing
The PFT results showed mildly altered FEV 1 and FVC values and mild to moderately reduced DLCO (Table 3) . According to the criteria of the European Respiratory Society, [12] one-third of patients had normal functional tests, but 67% of the population studied had some alteration of pulmonary function. The PFT alteration was characterized by a restrictive pattern in 58% of cases (mild in 52% of these cases), an obstructive pattern in 6%, and a mixed pattern in 3%. 
6-Min Walk Test
Patients covered a median of 366 m (318-411 m), a distance that represents between 60% and 65% of the theoretically predicted value. [13] , [14] With regard to oxygenation, the baseline pulse oximetry was 96% (96%-97%), with a median value of the minimum pulse oximetry of 93% (90%-94%). The prevalence of persistent pulmonary morbidity [11] was 11.5%.
High-Resolution CT Scanning
Morphologic alterations of the pulmonary parenchyma were detected in 76% of patients. An RP was the most common radiologic finding, followed by ground glass pattern and AD (Fig 4) . Nonetheless, in most patients, the alteration was limited to < 25% of lung parenchyma in the HRCT scan slice studied. A diffuse distribution was seen in 45% of the alterations observed, with involvement of the anterior lung fields predominating in 37% of patients and the posterior fields in only 18%.
Figure 4
Chest CT scan alterations detected at 6 months after ARDS. Black indicates that imaging alteration affects < 25% of the lung parenchyma in the CT scan slice. Dark gray indicates that alteration affects 25% to 50% of the lung parenchyma. Light gray indicates that alteration affects > 50% of the lung parenchyma. White indicates that no alterations were observed. 
Relationship Between HRQL and the Factors Analyzed
There were no differences in the HRQL based on the cause of ARDS or whether there was a septic origin of ARDS nor were there differences with respect to adjuvant treatments received during the hypoxemic phase. Analysis of the relationships between PFT results and overall HRQL showed no significant associations. However, separate analysis of each of the HRQL dimensions showed an inverse relationship between the energy dimension and the FEV 1 (r = -0.36, P < .05) and FVC (r = -0.36, P ≤ .05). There was no significant relationship between the HRQL results and the chest HRCT scan findings or 6-min walk test variables at 6 months following ARDS.
Comparative study of patients available for assessment at 1 month and 6 months showed a significant improvement in HRQL, PFT results, and radiologic findings. The most notable result was the positive correlation observed between the overall quality of life at 1 month and at 6 months (r = 0.68, P < .01) (Fig 5) .
Figure 5
Comparative study between overall quality of life assessed at 1 month and 6 months after ARDS. HRQL = health-related quality of life.
Discussion
To our knowledge, this is the first multicentric prospective study that evaluates quality of life, pulmonary function alterations, HRCT findings, and exercise test results in 6-month survivors of ARDS. The results show considerable alterations in HRQL in comparison with the healthy reference population. Moreover, most patients presented a mild restrictive pattern and DLCO decrease in PFT, accompanied by mild reticular alterations in CT scans and a moderate deficit in exercise capacity. Interestingly, an early HRQL study in these patients anticipated those who would present more HRQL morbidity in the long term. This is an important observation because early studies still might present residual noise signal from the distress inflammatory phase that would not allow the early detection of subsequent sequelae.
Our findings show that ARDS survivors have a poorer quality of life at 6 months compared with an agematched and sex-matched reference population from the same geographic area, which is mainly because of alterations in the dimensions focusing on the more physical components. Furthermore, a higher degree of social isolation has been observed in ARDS survivors. It may be a consequence, at least in part, of this alteration in physical domains. On the other hand, there was a robust relationship between the overall HRQL encountered at 1 month and at 6 months after ARDS, which indicates that identification of patients who will have a poor long-term quality of life is possible at an early time point. The decrease in HRQL is consistent with prior reports. [11] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] In fact, some studies have reported a reduction in HRQL after ARDS that was similar to, [23] or even worse [18] than, that seen in patients with other chronic diseases. Indeed, a meta-analysis of 557 patients grouped in 13 different cohorts [24] reported three important conclusions. First, studies using the 36-Item Short Form Health Survey (SF-36) [11] , [13] , [17] , [19] showed similar differences in HRQL, suggesting that the deterioration experienced by survivors was due to common factors. Second, the improvements seen in each dimension of the HRQL questionnaire were independent, and moreover, depended on the time at which they were measured. Lastly, survivors of ARDS presented a poorer HRQL compared with the age-matched and sex-matched reference population. Although most studies used SF-36 to evaluate HRQL, it is important to notice that significant alterations in HRQL were also observed when NHP was used. However, the characteristics of the test used may have influenced the results observed. Compared with SF-36, NHP may be less sensitive in detecting milder degrees of disease. However, NHP gives more coverage to emotional reaction, pain, and physical mobility. Moreover, unlike SF-36, NHP includes problems of sleep disturbance. Despite these differences, when a large cohort of patients with COPD was analyzed, both instruments had a similar ability to discriminate among different levels of respiratory impairment. [25] Nevertheless, to our knowledge, no data about comparisons of both tests in ARDS patients have been collected.
In the analysis of PFT, most survivors of ARDS presented a mild restrictive alteration and mild/moderate DLCO decrease. These results concur with published findings by other authors. [11] , [17] , [18] , [20] , [21] , [26] , [27] , [28] The most common tomographic pattern identified in our study was an RP, which mainly affected < 25% of the parenchyma in the CT scan sections analyzed. We found diffuse involvement in nearly one-third of the patients studied. Thus, it is likely that both ARDS and MV may contribute to these long-term alterations. However, the dependent areas alone, which are usually the most severely affected by consolidation during the acute phase of ARDS, were affected in only 18% of patients. Finally, a moderate decrease in the distance covered was observed, a finding consistent with the results reported by other authors. [11] , [21] , [29] It should be noted that in the first study of the Canadian Critical Care Trials Group, [11] weight loss, weakness, and significant fatigue were found in a considerable percentage of survivors. However, to date there have been no studies in which tests to diagnose critical illness myopathy/polyneuropathy have been performed in long-term survivors of ARDS. [30] Similar results were reported by Heyland et al, [20] who correlated overall HRQL at 1 year with age and previous comorbid conditions, and by Garland et al [31] in a study involving 1,700 patients with acute respiratory failure requiring MV. These facts, together with a persistent alteration in HRQL reported by different studies regardless of the test used, and the presence of only mild alterations on respiratory function observed, suggest that there is very likely an important extrapulmonary contribution to the persistent and significant alterations in the HRQL observed.
No differences in HRQL caused by respiratory distress were observed, in keeping with the results of Kim et al. [15] Nonetheless, Parker et al, [32] who studied a larger number of patients over a longer follow-up period, reported more favorable recovery of HRQL in patients with ARDS of intrapulmonary origin. Similar to previous data reported, [25] , [33] no differences were found in HRQL according to whether patients lay in the prone position or whether they received inhaled nitric oxide or steroids. However, patients who received any of these treatments were hypoxemic for a longer period and required more days of hospitalization. Lastly, in our study, the tidal volume applied during MV was not recorded. Nevertheless, no study in which the effect of a protective ventilation approach on HRQL and lung function was analyzed in survivors of ARDS [26] reported significant differences. There was no relationship between HRQL and PFT results, chest CT scan findings, or exercise capacity. This absence of significant associations may be explained by the multidimensionality and complexity of HRQL and the fact that most of the alterations detected were mild.
This study has some limitations that should be kept in mind when interpreting the results. The first of these was the difficulty in enrolling patients and following them up. We were able to include only one-half of survivors of ARDS, a percentage similar to those reported in the majority of the observational studies carried out in this line. The survivors included presented a higher percentage of women, required fewer days of MV and ICU hospitalization, and showed lower SOFA (Sequential Organ Failure Assessment) scores than did survivors who were not included. In addition, we excluded patients with previous respiratory disease or neurologic injury in an attempt to achieve a better estimation of the contribution of the ARDS itself to morbidity. If these patients had been included, the HRQL might have been even worse. Second, there was no optimal control group. In some studies, the HRQL of patients with ARDS has been compared with the HRQL of other critically ill survivors, whereas in other studies, the HRQL of patients with ARDS has been compared with the HRQL of the general population. [34] Third, HRQL is a purely subjective parameter, and the patient's quality of life before the critical event remained unknown. Fourth, no data about comorbidities and their possible influence on long-term sequelae were reported. Fifth, alterations observed may not have been definitive and they may have improved with longer follow-up. Finally, this study may have been underpowered to detect small differences in some of the reported measurements.
Conclusions
In summary, this study documented persistent alterations in HRQL at 6 months after critical illness, in comparison with a healthy reference population. Moreover, most patients presented mild/moderate radiologic and functional abnormalities. An early HRQL study in these patients enabled early detection of those who would present more 6-month HRQL morbidity. Therefore, early follow-up seems advisable, as well as performing follow-up after hospital discharge. These patients may benefit from implementation of multidisciplinary rehabilitation and treatment programs following ICU hospitalization, as in other pathologies. [35] 
